ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 706,89
0,00%
Dow Jones
39 411,21
0,67%
DAX
18 342,83
0,00%
Brent Oil
85,125
-0,17%
Bitcoin
61 110,30
1,40%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Anadys Pharmaceuticals (MM) (ANDS)

  7. Anadys Pharmaceuticals (MM) (ANDS) Actualités

ANDS

Anadys (ANDS)

Anadys Pharmaceuticals (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ANDS
DateHeureSourceTitreSymboleSociété
23/11/201122h10Edgar (US Regulatory)(25-NSE)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
23/11/201120h01Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
23/11/201107h39Dow Jones NewsRoche Buys Shares In Tender Offer For Anadys PharmaceuticalsNASDAQ:ANDSAnadys Pharmaceuticals (MM)
16/11/201112h02Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
14/11/201122h55Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
08/11/201114h16MarketwiredAcquisition Spotlight Shines on Hepatitis C Drug DevelopersNASDAQ:ANDSAnadys Pharmaceuticals (MM)
07/11/201123h01Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
07/11/201122h05PR Newswire (US)Anadys Pharmaceuticals Reports Third Quarter 2011 Financial Results and HighlightsNASDAQ:ANDSAnadys Pharmaceuticals (MM)
04/11/201121h34Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
26/10/201114h16MarketwiredPositive Test Results and Acquisitions Drive Shares of Exelixis and Anadys HigherNASDAQ:ANDSAnadys Pharmaceuticals (MM)
26/10/201112h02Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
25/10/201123h08Edgar (US Regulatory)Statement of Ownership: Solicitation (SC 14D9)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
25/10/201122h25Edgar (US Regulatory)Tender offer statement by Third Party (SC TO-T)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
24/10/201122h55Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
21/10/201116h53Business WireThe Law Firm of Weiss & Lurie Investigates Anadys Pharmaceuticals, Inc.NASDAQ:ANDSAnadys Pharmaceuticals (MM)
20/10/201121h39Business WireLaw Office of Brodsky & Smith, LLC Announces Investigation of Anadys Pharmaceuticals, Inc.NASDAQ:ANDSAnadys Pharmaceuticals (MM)
20/10/201112h08Dow Jones NewsRoche MS Drug's Good Test Results Boost Pipeline's ProspectsNASDAQ:ANDSAnadys Pharmaceuticals (MM)
20/10/201101h00Business WireFaruqi & Faruqi, LLP Announces Investigation of Anadys Pharmaceuticals, Inc.NASDAQ:ANDSAnadys Pharmaceuticals (MM)
19/10/201123h14Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
19/10/201119h12Business WireThe Law Firm of Levi & Korsinsky, LLP Announces Investigation of Anadys Pharmaceuticals Inc.NASDAQ:ANDSAnadys Pharmaceuticals (MM)
19/10/201105h30Business WireLaw Office of Brodsky & Smith, LLC Announces Investigation of Anadys Pharmaceticals, Inc.NASDAQ:ANDSAnadys Pharmaceuticals (MM)
18/10/201115h00MarketwiredAnalyst View, Impact of Global Events - Research Report on Anadys Pharmaceuticals, Inc. and Kinder Morgan Energy Partners LPNASDAQ:ANDSAnadys Pharmaceuticals (MM)
18/10/201102h32Business WireRobbins Umeda LLP Announces an Investigation of Anadys Pharmaceuticals, Inc.NASDAQ:ANDSAnadys Pharmaceuticals (MM)
18/10/201101h37Business WireRyan & Maniskas, LLP Announces Investigation of Anadys Pharmaceuticals Inc.NASDAQ:ANDSAnadys Pharmaceuticals (MM)
17/10/201120h42PR Newswire (US)The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Anadys...NASDAQ:ANDSAnadys Pharmaceuticals (MM)
17/10/201119h48Business WireTripp Levy PLLC Announces Investigation of Anadys PharmaceuticalsNASDAQ:ANDSAnadys Pharmaceuticals (MM)
17/10/201117h50ZacksRoche Targets Anadys Pharma - Analyst BlogNASDAQ:ANDSAnadys Pharmaceuticals (MM)
17/10/201116h50Edgar (US Regulatory)Written communication relating to an issuer or third party (SC TO-C)NASDAQ:ANDSAnadys Pharmaceuticals (MM)
17/10/201114h07PR Newswire (US)Anadys Announces Agreement To Be Acquired By RocheNASDAQ:ANDSAnadys Pharmaceuticals (MM)
17/10/201107h49Dow Jones NewsRoche To Acquire Anadys Pharmaceuticals, Inc. For $230 MillionNASDAQ:ANDSAnadys Pharmaceuticals (MM)
 Showing the most relevant articles for your search:NASDAQ:ANDS

Dernières Valeurs Consultées

USOTC
MSTLW
Morgan Stanley (PK)
NYSE
CPUH
Compute Health Acquisition
NASDAQ
GMFIW
Aetherium Acquisition
HITB
RLCBTC
ASX
NVADB
Nova Minerals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés